Daniel McCoy

Daniel McCoy is a highly accomplished professional with a solid educational background and extensive experience in molecular biology and gene therapy.

Having completed a PhD in Molecular Biology from the University of Southern California and a BS in Biology from Wake Forest University, Daniel's academic foundation is robust and comprehensive.

Throughout his career journey, Daniel has held key roles in various prestigious organizations, including serving as the Associate Director of Preclinical Programs at Jaguar Gene Therapy, where he demonstrates leadership and expertise in overseeing the development of gene therapy programs.

Previously, Daniel has contributed his scientific acumen as a Scientific Advisor at Rarebase, a Senior Scientist in Gene Therapy at BridgeBio, and a Director at Daddy Daycare.

His experience also includes positions such as Principal Scientist in Platform Development at StrideBio, Inc, Investigator in Translational Science at GSK, Postdoctoral Associate at Duke University, and Associate Scientist III at Sanofi Pasteur.

Daniel has a wide-ranging professional background, having excelled in various roles that highlight his versatile skill set and deep understanding of molecular biology and gene therapy.

His diverse experience encompasses working in both industry and academic settings, illustrating his ability to adapt to different environments and effectively contribute to groundbreaking research and program development.

Through his tenure as a Summer Intern and Contract Scientist at Pfizer, a Summer Intern at Biogen, and his PhD studies at the University of Southern California, Daniel has consistently showcased his passion for advancing scientific knowledge and innovation.

As a seasoned professional in the field of molecular biology, Daniel McCoy continues to make significant contributions and drive advancements in gene therapy, showcasing his dedication to pioneering research and development in the biotechnology sector.